|
|
Volumn 2, Issue 2, 2004, Pages 41-42
|
|
Erectile dysfunction
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
PHOSPHODIESTERASE V INHIBITOR;
PROSTAGLANDIN E1;
SILDENAFIL;
TADALAFIL;
VARDENAFIL;
CARDIOVASCULAR DISEASE;
CLINICAL PRACTICE;
COMORBIDITY;
COST EFFECTIVENESS ANALYSIS;
DIAGNOSTIC PROCEDURE;
DRUG EFFICACY;
DRUG HALF LIFE;
DRUG SAFETY;
EDITORIAL;
ERECTILE DYSFUNCTION;
EXERCISE;
HUMAN;
ISCHEMIC HEART DISEASE;
LABORATORY TEST;
MALE;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PENIS PROSTHESIS;
PHYSICAL EXAMINATION;
PROSTATECTOMY;
RISK FACTOR;
SEXUAL BEHAVIOR;
SEXUAL INTERCOURSE;
TREATMENT FAILURE;
TREATMENT OUTCOME;
TREATMENT PLANNING;
UROLOGY;
VASCULAR SURGERY;
|
|
EID: 12444292788
PISSN: 15709124
EISSN: None
Source Type: Journal
DOI: 10.1016/j.euus.2004.03.004 Document Type: Editorial |
|
Times cited : (2)
|
|
References (0)
|
